The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome

Aim. Clinical assessment of the use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome (DFS). Materials and methods. The study included 24 patients with DM1 and DM2 and neuropathic or neuroischemic forms of DFS in the absence of pronounced...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Vladimir Nikolaevich Khramilin
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2010
Materias:	diabetic foot syndrome lipid-colloid technology dressing materials Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/f7f80900ea664a5abe740055830b3975
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f7f80900ea664a5abe740055830b3975
record_format	dspace
spelling	oai:doaj.org-article:f7f80900ea664a5abe740055830b39752021-11-14T09:00:15ZThe use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome2072-03512072-037810.14341/2072-0351-5501https://doaj.org/article/f7f80900ea664a5abe740055830b39752010-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5501https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. Clinical assessment of the use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome (DFS). Materials and methods. The study included 24 patients with DM1 and DM2 and neuropathic or neuroischemic forms of DFS in the absence of pronounced leg ischemia (ankle-brachial index >0.7). Duration of the observation period was 8 weeks, the patients were examined once in 2 weeks. The dressing materials used in the study were based on the Cellosorb NA, Cellosorb Ag, Urgotul S Ag. technology (Laboratories Urgo). Efficacy and safety of the dressing materials were estimated from the wound size, degree of exudation, characteristics of the wound bed and the surrounding tissues. The data obtained were treated using Statistica v. 7.0 software (StatSoft Inc.). Results. Efficacy of local therapy was assessed based on the Pressure Ulcer Scale of Healing (PUSH). Neither local nor systemic adverse events related to the use of the above dressing materials were registered during the follow-up. Cellosorb NA and Cellosrb Ag hydrocellular dressings showed high absorption activity and atraumatic properties. Most patients especially those using Cellosorb Ag were free from local infection. Conclusion. Dressing materials based on the lipid-colloid technology are safe and meet all requirements for the means of local treatment of chronic wounds.Vladimir Nikolaevich KhramilinEndocrinology Research Centrearticlediabetic foot syndromelipid-colloid technologydressing materialsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 13, Iss 3, Pp 129-132 (2010)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetic foot syndrome lipid-colloid technology dressing materials Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetic foot syndrome lipid-colloid technology dressing materials Nutritional diseases. Deficiency diseases RC620-627 Vladimir Nikolaevich Khramilin The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
description	Aim. Clinical assessment of the use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome (DFS). Materials and methods. The study included 24 patients with DM1 and DM2 and neuropathic or neuroischemic forms of DFS in the absence of pronounced leg ischemia (ankle-brachial index >0.7). Duration of the observation period was 8 weeks, the patients were examined once in 2 weeks. The dressing materials used in the study were based on the Cellosorb NA, Cellosorb Ag, Urgotul S Ag. technology (Laboratories Urgo). Efficacy and safety of the dressing materials were estimated from the wound size, degree of exudation, characteristics of the wound bed and the surrounding tissues. The data obtained were treated using Statistica v. 7.0 software (StatSoft Inc.). Results. Efficacy of local therapy was assessed based on the Pressure Ulcer Scale of Healing (PUSH). Neither local nor systemic adverse events related to the use of the above dressing materials were registered during the follow-up. Cellosorb NA and Cellosrb Ag hydrocellular dressings showed high absorption activity and atraumatic properties. Most patients especially those using Cellosorb Ag were free from local infection. Conclusion. Dressing materials based on the lipid-colloid technology are safe and meet all requirements for the means of local treatment of chronic wounds.
format	article
author	Vladimir Nikolaevich Khramilin
author_facet	Vladimir Nikolaevich Khramilin
author_sort	Vladimir Nikolaevich Khramilin
title	The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
title_short	The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
title_full	The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
title_fullStr	The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
title_full_unstemmed	The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
title_sort	use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
publisher	Endocrinology Research Centre
publishDate	2010
url	https://doaj.org/article/f7f80900ea664a5abe740055830b3975
work_keys_str_mv	AT vladimirnikolaevichkhramilin theuseofdressingmaterialsbasedonthelipidcolloidtechnologyforthelocaltreatmentofdiabeticfootsyndrome AT vladimirnikolaevichkhramilin useofdressingmaterialsbasedonthelipidcolloidtechnologyforthelocaltreatmentofdiabeticfootsyndrome
_version_	1718429625845022720

The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome

Ejemplares similares